Veklury Injection, Powder, Lyophilized, For Solution
Product Images NDC 61958-2901

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Veklury (NDC 61958-2901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Veklury 01)

Chemical structure of Veklury (Remdesivir), showing its complex molecular arrangement with a phosphoramidate prodrug moiety, a ribose sugar, and a nucleobase analog portion. The diagram displays atoms and bonds characteristic of the antiviral agent's structure.*

FDA Label Image

Principal Display Panel (100 mg/20 mL Vial Label)

Label for Veklury (remdesivir) injection 100 mg/20 mL (5 mg/mL) single-dose vial. The label indicates the product must be diluted prior to use for intravenous infusion, includes storage instructions, manufacturer Gilead Sciences, and NDC 61958-2902-2.*

FDA Label Image

Principal Display Panel (100 mg/20 mL Vial Carton)

Packaging label for Veklury (remdesivir) injection 100 mg/20 mL (5 mg/mL) by Gilead Sciences, Inc. The label indicates a single-dose vial that must be diluted prior to use for intravenous infusion and stored refrigerated. Key information includes the NDC 61958-2902-2 and instructions to discard unused portions.*

FDA Label Image

Principal Display Panel (100 mg Vial Label)

Veklury (remdesivir) for injection 100 mg per vial single-dose vial label. The label instructs that it must be reconstituted and further diluted prior to use for intravenous infusion. It includes storage instructions and manufacturer information for Gilead Sciences, Inc.*

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Carton packaging for Veklury (remdesivir) 100 mg/vial injection by Gilead Sciences, Inc. The label indicates a single-dose vial with instructions to discard unused portion. It includes warnings that the powder must be reconstituted and further diluted before intravenous infusion. The packaging also displays storage instructions and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.